DanielleSchenoneWallaceMD

PubMed

• ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.
  Giby V George, Danielle S Wallace, Ying Wang, John Carney, Murad Elsadawi, W Richard Burack, Andrew G Evans, Moises J Velez, Siba El Hussein, Barr, P. M., Barr, P. M.,...> ;Histopathology. 2024 Apr 1
• Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.
  Danielle S Wallace, Chris Rowland, Brian T Hill, Andrea M Baran, Carla Casulo, Patrick M Reagan, Allison Winter, Reem Karmali, Jane N Winter, Leo I Gordon, Andrew Bui,...> ;Leukemia & Lymphoma. 2023 Sep 1
• 4 citations
  Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia.
  Danielle S Wallace, Clive S Zent, Andrea M Baran, Patrick M Reagan, Carla Casulo, Geoffrey Rice, Jonathan W Friedberg, Paul M Barr> ;Blood Advances. 2023 Jun 13
• 1 citations
  Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions.
  Jeremiah E Moore, Paige C Bloom, Charles C Chu, Jennifer E Bruno, Christine A Herne, Andrea M Baran, Sally A Quataert, Timothy R Mosmann, Ronald P Taylor, Danielle S W...> ;Leukemia Research. 2023 Jun 1
• 1 citations
  Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
  Franklin Li, Gradon Nielsen, Andrea Baran, John Hu, Danielle Wallace, Matthew Preslar, Fergal J. Fleming, Larissa K. Temple, Richard F. Dunne, Marcus Smith Noel, Aram ...> ;Clinical Colorectal Cancer. 2020 Apr 14
• Tale of Two Livers
  Danielle Wallace, MD> ;JAMA. 2017 Feb 28
• Join now to see all